Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
Research fellow in Cancer Immunology
| Dyddiad hysbysebu: | 14 Mai 2025 |
|---|---|
| Cyflog: | £36,130 i £40,497 bob blwyddyn |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 28 Mai 2025 |
| Lleoliad: | Southampton, Hampshire |
| Gweithio o bell: | Ar y safle yn unig |
| Cwmni: | University of Southampton |
| Math o swydd: | Dros dro |
| Cyfeirnod swydd: | 3097825CM |
Crynodeb
The Antibody and Vaccine Group based in the Centre for Cancer Immunology in Southampton has a strong track-record in basic and translational immunology. One of its central aims is to develop new and more effective antibody reagents for treating cancer.
An exciting opportunity now presents itself for a research fellows to work on a Cancer Research Horizons-funded project to develop a novel antibody technology towards clinical investigation. The post-holder will leverage expertise in antibody biology and engineering, immune receptor agonism and T cell biology in order to gain new understanding of how the new technology works and compares with existing drugs with the aim of improving cancer treatments.
You will be motivated, educated to PhD level in a relevant subject area and ideally have practical laboratory experience of antibody biology, T cells and in vivo methodology.
Informal queries should be directed to Professor Mark Cragg (msc@soton.ac.uk)
Details about the School of Cancer Sciences and Centre for Cancer Immunology can be found at https://www.southampton.ac.uk/medicine/research/themes/cancer-sciences.page and Centre for Cancer Immunology | University of Southampton
Applications will be considered from candidates who are working towards or nearing completion of a relevant PhD qualification. The title of Research Fellow will be applied upon completion of PhD. Prior to the qualification being awarded the title of Senior Research Assistant will be given.
An exciting opportunity now presents itself for a research fellows to work on a Cancer Research Horizons-funded project to develop a novel antibody technology towards clinical investigation. The post-holder will leverage expertise in antibody biology and engineering, immune receptor agonism and T cell biology in order to gain new understanding of how the new technology works and compares with existing drugs with the aim of improving cancer treatments.
You will be motivated, educated to PhD level in a relevant subject area and ideally have practical laboratory experience of antibody biology, T cells and in vivo methodology.
Informal queries should be directed to Professor Mark Cragg (msc@soton.ac.uk)
Details about the School of Cancer Sciences and Centre for Cancer Immunology can be found at https://www.southampton.ac.uk/medicine/research/themes/cancer-sciences.page and Centre for Cancer Immunology | University of Southampton
Applications will be considered from candidates who are working towards or nearing completion of a relevant PhD qualification. The title of Research Fellow will be applied upon completion of PhD. Prior to the qualification being awarded the title of Senior Research Assistant will be given.
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.